About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Endometrial Injury and Single Embryo Transfer | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01851876

Endometrial Injury and Single Embryo Transfer

Endometrial injury increases clinical pregnancy rate in normoresponder patients undergoing long agonist protocol intracytoplasmic sperm injection cycles with single embryo transfer.

Lead sponsor: Karadeniz Technical University•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Karadeniz Technical University

Endometrial injury means endometrial biopsy on day 3 of menstrual cycle following down regulation in an IVF patient.

Age

18 - 35 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•woman age under 35 years
•history of primary infertility
•normoresponder (antral follicle count 5-10 in one ovary in early follicular phase
•having grade I or II embryos for transfer
•agree to undergo endometrial biopsy during the COH cycle. All patients were stimulated with luteal phase long protocol.

Exclusion Criteria

•endocrinopathies (including diabetes mellitus, hyperprolactinemia, Cushing's disease, and congenital adrenal hyperplasia), any systemic disease, collagen disorder, hypercholesterolemia, sickle cell anemia, and a history of neoplasm; -high risk for or history of OHSS
•using any concurrent medication (e.g., insulin-sensitizing drugs, and GnRH antagonists)
•patients who did not proceed to follicle retrieval
•severe male infertility requiring TESA/TESA
•mullerian tract anomalies
•a history of endometrial instrumentation or surgery within a month of the study
•not agree to undergo endometrial biopsy during the COH cycle.

Related studies

Not Yet RecruitingNA

Effects of Virtual Reality Glasses and Meditation Music on Anxiety, Pain, Vital Signs, Satisfaction and Pregnancy Outcomes in Embryo Transfer Procedure

NCT06802692 · Being Diagnosed With Primary Infertility, Having Had an Embryo Transfer for the First Time

Minimal Stimulation Protocol Using Aromek(Letrozole) and Follitrope(recFSH) Combined With INVOCell-Low Cost IVF

NCT01058252 · Primary Infertility, Secondary Infertility, and more

Routine Hysteroscopy in IVF/ICSI Cycles in Patients With Primary Unexplained Infertility

NCT02416596 · Primary Infertility Unspecified, Infertility, and more

LANDA Embryo Freezing Technique.

NCT01271400 · Primary Infertility, Secondary Infertility, and more

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 1, 2013Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment118

Start dateSep 2010

Last updatedJul 1, 2013

Condition

Primary Infertility

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 1, 2013Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions